LUYE PHARMA News

LUYE PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024

Sep 4 04:51 ET

LUYE PHARMA: VOLUNTARY ANNOUNCEMENT -APPROVAL OBTAINED FOR INITIATING CLINICAL TRIALS FORInnovative Dual TAAR1/5-HT2CR Agonist (LY03020)

Aug 5 07:02 ET

LUYE PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024

Aug 5 02:13 ET

LUYE PHARMA: VOLUNTARY ANNOUNCEMENT - ERZOFRI (PALIPERIDONE PALMITATE) EXTENDED-RELEASEINJECTABLE SUSPENSION APPROVED BY THE FDA FORTREATMENT OF SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER

Jul 28 07:00 ET

LUYE PHARMA: VOLUNTARY ANNOUNCEMENT - MIMEIXIN (OXYCODONE HYDROCHLORIDE ANDNALOXONE HYDROCHLORIDE SUSTAINED-RELEASE TABLETS)APPROVED FOR MARKETING IN CHINA

Jul 4 07:00 ET

LUYE PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024

Jul 2 05:55 ET

LUYE PHARMA: VOLUNTARY ANNOUNCEMENT - THE MANUFACTURING FACILITY OF PALIPERIDONE PALMITATEEXTENDED-RELEASE INJECTABLE SUSPENSION (LY03010) HASPASSED PAI BY U.S. FDA WITH NO FDA-483

Jun 27 09:45 ET

LUYE PHARMA: VOLUNTARY ANNOUNCEMENT -JINYOUPING (ROTIGOTINE MICROSPHERES FOR INJECTION)APPROVED FOR MARKETING IN CHINA

Jun 20 07:00 ET

LUYE PHARMA: VOLUNTARY ANNOUNCEMENT - MEIBIRUI (PALIPERIDONE PALMITATE INJECTION)APPROVED FOR MARKETING IN CHINA

Jun 11 08:00 ET

LUYE PHARMA: VOLUNTARY ANNOUNCEMENT - NDA FILED FOR RIVASTIGMINE TWICE WEEKLY TRANSDERMALPATCH IN JAPAN

Jun 6 05:00 ET

LUYE PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024

Jun 3 23:11 ET

LUYE PHARMA: Notification Letter and Request Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

May 28 10:42 ET

LUYE PHARMA: Notification Letter and Request Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

May 28 10:41 ET

LUYE PHARMA: Altered Memorandum of Association and Bye-laws

May 28 10:41 ET

LUYE PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 6 04:50 ET

LUYE PHARMA: FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETINGTO BE HELD ON 28 MAY 2024

Apr 29 10:56 ET

LUYE PHARMA: Environmental, Social and Governance Report 2023

Apr 29 10:54 ET

LUYE PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 8 05:16 ET

LUYE PHARMA: VOLUNTARY ANNOUNCEMENT - FIRST PATIENT ENROLLED FOR PHASE 3 CLINICAL STUDY OF THE GROUP''S INNOVATIVE FORMULATION LY01610

Mar 4 07:30 ET

LUYE PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Mar 1 03:38 ET